We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$186B
AUM Growth
-$3.03B
Cap. Flow
-$12.6B
Cap. Flow %
-6.79%
Top 10 Hldgs %
36.88%
Holding
5,437
New
555
Increased
2,585
Reduced
1,271
Closed
755

Sector Composition

Rank Sector Weight
1 Technology 12.52%
2 Financials 7.65%
3 Consumer Discretionary 5.72%
4 Communication Services 5.59%
5 Healthcare 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTLC icon
4476
Pacer Trendpilot US Large Cap ETF
PTLC
$3.19B
$3K ﹤0.01%
+93
New +$3.14K
PXJ icon
4477
Invesco Oil & Gas Services ETF
PXJ
$63.3M
$3K ﹤0.01%
200
SCM icon
4478
Stellus Capital Investment Corp
SCM
$205M
$3K ﹤0.01%
+200
New +$2.29K
SEF icon
4479
ProShares Short Financials
SEF
$13.2M
$3K ﹤0.01%
50
SHG icon
4480
Shinhan Financial Group
SHG
$32.1B
$3K ﹤0.01%
+79
New +$2.39K
TWIN icon
4481
Twin Disc
TWIN
$321M
$3K ﹤0.01%
+317
New +$2.81K
XENE icon
4482
Xenon Pharmaceuticals
XENE
$6.1B
$3K ﹤0.01%
182
+96
+112% +$1.63K
ZYNE
4483
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$3K ﹤0.01%
739
+734
+14,680% +$3.33K
PRVB
4484
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$3K ﹤0.01%
318
+123
+63% +$1.73K
APEN
4485
DELISTED
Apollo Endosurgery, Inc.
APEN
$3K ﹤0.01%
+499
New +$2.47K
ZNH
4486
DELISTED
China Southern Airlines Company Limited
ZNH
$3K ﹤0.01%
71
-2,190
-97% -$71.1K
IPFF
4487
DELISTED
iShares International Preferred Stock ETF
IPFF
$3K ﹤0.01%
207
ACU icon
4488
Acme United Corp
ACU
$228M
$2K ﹤0.01%
+50
New +$1.76K
AP icon
4489
Ampco-Pittsburgh
AP
$163M
$2K ﹤0.01%
+290
New +$2.12K
BBDC icon
4490
Barings BDC
BBDC
$869M
$2K ﹤0.01%
+200
New +$1.9K
BWEN icon
4491
Broadwind
BWEN
$81.7M
$2K ﹤0.01%
+309
New +$2.48K
CAAP icon
4492
Corporacion America
CAAP
$4.17B
$2K ﹤0.01%
+413
New +$1.78K
CATX icon
4493
Perspective Therapeutics
CATX
$327M
$2K ﹤0.01%
+174
New +$2.63K
CPSH icon
4494
CPS Technologies
CPSH
$67.6M
$2K ﹤0.01%
+189
New +$2.63K
CRVS icon
4495
Corvus Pharmaceuticals
CRVS
$1.1B
$2K ﹤0.01%
537
+533
+13,325% +$1.93K
FOCL
4496
EDAP TMS S.A.
FOCL
$234M
$2K ﹤0.01%
+191
New +$1.55K
FTEK icon
4497
Fuel Tech
FTEK
$43M
$2K ﹤0.01%
+498
New +$2.19K
ISSC icon
4498
Innovative Solutions & Support
ISSC
$319M
$2K ﹤0.01%
+324
New +$2.07K
LPTH icon
4499
Lightpath Technologies
LPTH
$590M
$2K ﹤0.01%
+515
New +$1.96K
M icon
4500
CALL
Macy's
M
$6.51B
$2K ﹤0.01%
100
-244,500
-100% -$3.73M

Similar funds

Barclays's Q1 2021 Portfolio in Review

As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Barclays opened a new position in Ferguson worth $253M.

  • Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
  • Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
  • Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
  • Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
  • Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
  • Barclays opened 555 new positions and closed 755 in Q1 2021.
  • Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.

Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.